Capstone Investment Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,150
| Closed | -$57.2K | – | 845 |
|
|
2025
Q1 | $57.2K | Buy |
+16,150
| New | +$57.2K | ﹤0.01% | 511 |
|
|
2024
Q2 | – | Sell |
-80,084
| Closed | -$227K | – | 1037 |
|
|
2024
Q1 | $227K | Buy |
80,084
+60,084
| +300% | +$171K | ﹤0.01% | 1135 |
|
|
2023
Q4 | $294K | Sell |
20,000
-2,829
| -12% | -$41.6K | ﹤0.01% | 708 |
|
|
2023
Q3 | $418K | Buy |
+22,829
| New | +$418K | ﹤0.01% | 659 |
|
|
2023
Q2 | – | Sell |
-10,150
| Closed | -$298K | – | 864 |
|
|
2023
Q1 | $298K | Buy |
+10,150
| New | +$298K | ﹤0.01% | 398 |
|